Form 4 for CSBR CHAMPIONS ONCOLOGY, INC.
Accepted 2022-10-20 00:00:00 ET · period of report 2022-10-19 · accession 0001628280-22-026743 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-10-20 | 2022-10-19 | CSBR | ACKERMAN JOEL | Dir | M - OptEx | $3.21 | +16.7K | 1.46M | +1% | +$53.5K |
| D | 2022-10-20 | 2022-10-19 | CSBR | ACKERMAN JOEL | Dir | M - OptEx | $0.00 | +16.7K | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-19 | M | A | 16,667 | $3.21 | 1,460,595 | D | — | — | |
| 2 | Derivative | Option to purchase Common Stock | 2022-10-19 | M | A | 16,667 | $0.00 | 0 | D | $3.21 · — to 2022-10-31 | 16,667 Common Stock | (F1) The options vest and are exercisable over a twelve month period, with vesting to occur on November 8, 2017, February 8, 2018, May 8, 2018 and August 8, 2018, respectively. |